相关实验视频

Updated: May 12, 2026

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Published on: July 26, 2011

在5xFAD中空间模式分离的脆弱性阿尔茨海默氏症老鼠模型

Lucas Gephine¹, Candice M Roux¹, Thomas Freret¹

¹Normandie Université, UNICAEN, INSERM, COMETE, CYCERON, CHU Caen, Caen, France.

Journal of Alzheimer's disease : JAD

|February 2, 2024

概括

空间模式分离 (SPS) 功能对记忆至关重要,在使用对象探索任务的5xFAD小鼠中显示出早期的缺陷. 这一发现有助于理解阿尔茨海默病 (AD) 的进展,并开发新的治疗方法.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
行为科学行为科学

背景情况:

阿尔茨海默病 (AD) 是导致痴呆的主要原因,其特点是记忆力下降和海马体功能障碍.
空间模式分离 (SPS) 障碍可能表明早期的AD.
5xFAD转基因小鼠模型用于研究AD的前阶段.

研究的目的:

用5xFAD小鼠模型评估在阿尔茨海默病 (AD) 的前阶段的空间模式分离 (SPS) 性能.
调查与AD病变发生相关的早期认知缺陷.

主要方法:

在4个月大的雄性野生型 (WT) 和5xFAD小鼠 (每组n=14) 中,空间模式分离 (SPS) 的行为评估.
使用了两个已验证的SPS范式:自发对象探索和触摸屏系统.
监测运动运动活动和类似焦虑的行为,以控制混因素.

主要成果:

与WT littermates相比,5xFAD小鼠在对象识别任务中表现出SPS的轻微缺陷.
在基于触摸屏的SPS任务中,在5xFAD和WT小鼠之间没有观察到显著的性能差异.
运动活动和焦虑水平在两组之间是可比的,排除它们作为混变量.

结论:

空间模式分离 (SPS) 功能在5xFAD小鼠模型的早期是脆弱的,特别是在涉及自发探索的任务中.
这项研究提供了对阿尔茨海默病 (AD) 中情节性记忆衰退背后的早期神经生物学过程的见解.
这些发现可能有助于开发新的阿尔茨海默病治疗策略.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.认知障碍认知障碍认知障碍转基因小鼠转基因小鼠

更多相关视频

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

相关概念视频

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...